Comparison of effects of aminosalicylic acid, glucocorticoids and immunosuppressive agents on the expression of multidrug-resistant genes in ulcerative colitis

Comparison of effects of aminosalicylic acid, glucocorticoids and immunosuppressive agents on the expression of multidrug-resistant genes in ulcerative colitis

Abstract To compare the effects of aminosalicylic acid, glucocorticoids and immunosuppressants on the expression levels of multidrug resistance genes in patients with ulcerative colitis (UC), with the aim of providing a theoretical and therapeutic basis for the diagnosis, treatment, and prevention o...

Full description

Bibliographic Details
Main Authors:	Yan Chen, Ping Wang, Yin Zhang, Xiao-Yu Du, Ying-Jian Zhang
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-11-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-19612-8

Similar Items

Cytokines and mechanisms of action of glucocorticoids and aminosalicylates in the treatment of ulcerative colitis and Crohn's disease.
by: Zimmerman, M, et al.
Published: (1996)

Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids.
by: Juan Suárez, et al.
Published: (2012-01-01)

5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis
by: Jun Miyoshi, et al.
Published: (2018-10-01)

5-Aminosalicylic Acid Alters the Gut Bacterial Microbiota in Patients With Ulcerative Colitis
by: Jun Xu, et al.
Published: (2018-06-01)

Synthesis and evaluation of a prodrug of 5-aminosalicylic acid for the treatment of ulcerative colitis
by: Yan Yan, et al.
Published: (2019-12-01)

Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis
by: Tripathi K, et al.
Published: (2021-08-01)

USE OF 5-AMINOSALICYLIC ACID FOR TREATMENT OF ULCERATIVE COLITIS IN DIFFERENT DOSAGE MODES
by: M. V. Shapina, et al.
Published: (2017-11-01)

5-Aminosalicylic Acid-induced Myocarditis in a Patient with Atypical Ulcerative Colitis
by: Hyo Yeop Song, et al.
Published: (2022-01-01)

Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials
by: Yong Jiang, et al.
Published: (2016-03-01)

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
by: Soo-Kyung Park, et al.
Published: (2022-09-01)

Factors associated with low adherence to oral 5-aminosalicylic acid in patients with ulcerative colitis.
by: Jin Lee, et al.
Published: (2019-01-01)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
by: Hugh James Freeman
Published: (2012-01-01)

Medical Management of Ulcerative Colitis with a Specific Focus on 5-Aminosalicylates
by: Hugh James Freeman
Published: (2012-10-01)

Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis.
by: O'Donnell, L, et al.
Published: (1992)

Clinical Background Factors as Predictors of the Efficacy of 5-Aminosalicylic Acid Suppositories in Patients with Ulcerative Colitis
by: Kazuhiko Uchiyama, et al.
Published: (2023-08-01)

5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report
by: Asuka Watanabe, et al.
Published: (2024-01-01)

5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis
by: Shinta Mizuno, et al.
Published: (2020-01-01)

5-Aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated meta-analysis.
by: Li-Na Zhao, et al.
Published: (2014-01-01)

THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE
by: O. V. Knyazev, et al.
Published: (2018-01-01)

Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase
by: Akira Madarame, et al.
Published: (2021-01-01)

Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study
by: Reidar Fossmark, et al.
Published: (2021-06-01)

Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase.
by: Akira Madarame, et al.
Published: (2021-01-01)

Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
by: Xin Zhao, et al.
Published: (2016-01-01)

Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy
by: Dagmar Schierová, et al.
Published: (2020-10-01)

The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBD registry.
by: Tomohiro Fukuda, et al.
Published: (2017-01-01)

Aminosalicylates
by: Williams C
Published: (2001-01-01)

Efficacy and safety of oral beclomethasone dipropionate and budesonide MMX 5-aminosalicylates or placebo in ulcerative colitis: a systematic review and meta-analysis
by: Brigida Barberio, et al.
Published: (2023-07-01)

Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial
by: Zhaofeng Shen, et al.
Published: (2021-01-01)

Integrated Analysis Reveals the Targets and Mechanisms in Immunosuppressive Effect of Mesalazine on Ulcerative Colitis
by: Rong Li, et al.
Published: (2022-05-01)

Conjugation of Amisulpride, an Anti-Psychotic Agent, with 5-Aminosalicylic Acid via an Azo Bond Yields an Orally Active Mutual Prodrug against Rat Colitis
by: Wooseong Kim, et al.
Published: (2019-11-01)

Sonoelectrochemically enhanced determination of 5-aminosalicylic acid.
by: Beckett, E, et al.
Published: (2001)

Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis
by: Chunlan Huang, et al.
Published: (2022-08-01)

Addition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 Mice.
by: Yan-hong Li, et al.
Published: (2015-01-01)

The effect of pre-admission immunosuppression on colectomy rates in acute severe ulcerative colitis
by: Desmond Patrick, et al.
Published: (2018-11-01)

Mechanism of action of 5-aminosalicylic acid and its derivatives.
by: Ireland, A, et al.
Published: (1990)

Electroanalytical Overview: The Sensing of Mesalamine (5-Aminosalicylic Acid)
by: Robert D. Crapnell, et al.
Published: (2023-12-01)

5-Aminosalicylic acid alters the gut microbiota and altered microbiota transmitted vertically to offspring have protective effects against colitis
by: Haruka Wada, et al.
Published: (2023-07-01)

Comparison of 5-aminosalicylic acid and N-acetylaminosalicylic acid uptake by the isolated human colonic epithelial cell.
by: Ireland, A, et al.
Published: (1992)

Mycotic aneurysms due to Trichosporon asahii in a patient with ulcerative colitis under immunosuppression
by: Juan Luis Quintana, et al.
Published: (2023-01-01)

A Case of Lung Abscess Caused by Double Immunosuppressive Therapy to Treat Ulcerative Colitis
by: Keiichi Tominaga, et al.
Published: (2020-11-01)